Sandra Heskamp studied Biomedical Sciences at the Radboud University of Nijmegen. In 2009, she graduated in two master’s: Epidemiology and Biostatistics and Human Pathobiology. That same year she started her PhD project “Molecular imaging of receptor tyrosine kinases in cancer” at the Department of Radiology and Nuclear Medicine of the Radboudumc. In addition, she performed a research internship at the Technical University in Munich to study the potential of targeted radionuclide therapy with alpha-emitting radionuclides. She obtained her PhD in June 2014 and started working as a post-doc, followed by a tenure-track position. In 2021, she was appointed as a professor in Nuclear Imaging and Therapy in Immuno-Oncology at the Radboudumc. Her research focuses on novel radiotracers to visualize tumor cells and their (immune)microenvironment, to study the biology of cancer in in vivo settings. In addition, she works on therapeutic radiotracers and studies their radiobiological and immunological effects.